Israel’s Silexion Therapeutics reported that its SIL-204 pancreatic cancer treatment effectively reduces primary tumor growth and secondary cancer spread. Silexion ‘s first generation LODER treatment already had good results in Phase 2 trials on “simple” cancers. https://silexion.com/wp-content/uploads/2025/02/silexion-therapeutics-announces-completion-of1.pdf

Israel’s Profuse (see here previously) which specializes in the laboratory cultivation of muscle tissue for non-animal meat, has launched a new technology and program for preventing and restoring muscle lost by the growing use of weight-loss treatments, aging, and cancer. … Continue reading →

Israel hosted the “Lifetime Partnership” International Rehabilitation Conference in Tel Aviv. It attracted medical and rehabilitation experts from militaries, defense ministries, and health departments in England, Thailand, Germany, Hungary, the Czech Republic, Brazil and Canada. https://www.timesofisrael.com/israel-hosts-first-ever-international-rehabilitation-conference-in-wake-of-oct-7/

Israel’s Treat Me (see here) has developed an AI-driven platform that allows practitioners to create tailor-made treatment plans that bridge Western medicine, complementary therapies (e.g. Chinese medicine, naturopathy, reflexology) and cutting-edge research. https://www.israel21c.org/mom-turns-medical-nightmare-into-an-integrative-care-dream/ https://www.treatme.ltd/

Israel’s Arcuro Medical (see here previously) has received US FDA clearance for its SuperBall-RC system for use in rotator cuff (shoulder) repair procedures. Arcuro’s SuperBall technology platform has now successfully been used in over 5,000 meniscus (knee) repairs. https://www.prnewswire.com/news-releases/arcuro-medical-announces-fda-510k-clearance-for-the-superball-rc-for-rotator-cuff-indications-302387137.html

Hebrew University of Jerusalem scientists have discovered how the bacteria Porphyromonas gingivalis causes periodontitis infection (gum disease). Preventing it binding to protein CD47 prevents periodontitis, and its correlation with cardiovascular disease, Alzheimer’s, and cancer. https://www.afhu.org/2025/02/24/new-approach-to-suppress-oral-bacteria-that-cause-periodontal-and-other-disease-symptoms-discovered-by-hu-researchers/ https://www.pnas.org/doi/10.1073/pnas.2405534121

Israel’s Inspira Technologies (see here previously) announced positive results from the clinical study at Sheba Hospital of its AI-powered HYLA blood sensor. Its real-time blood monitoring enables early diagnosis and personalized care without the need for intermittent blood draws. https://www.prnewswire.com/news-releases/inspira-technologies-announces-positive-results-from-clinical-study-of-hyla-blood-sensor-achieving-96-accuracy-302391551.html